Data Horizon Co

Data Horizon Co ROE

The Return on Equity (ROE) of Data Horizon Co (3628.T) as of Nov 6, 2026 is 56.25 %. In the previous year, Return on Equity (ROE) was -1,782.91 % — a change of -103.15% (higher).

ROE

56.25 %

YoY

-103.15%

Last updated:

In 2026, Data Horizon Co's return on equity (ROE) was 56.25 %, a -103.15% increase from the -1,782.91 % ROE in the previous year.

The Data Horizon Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
1.90 JPY
Jan 1, 2020
15.70 JPY
Jan 1, 2021
18.39 JPY
Jan 1, 2022
-32.71 JPY
Jan 1, 2023
-16.76 JPY
Jan 1, 2024
-25.29 JPY
Jan 1, 2025
-1,782.91 JPY
Jan 1, 2026
56.25 JPY
The Data Horizon Co ROE history
YEARROEYoY
56.25 %-103.15%
-1,782.91 %+6,949.70%
-25.29 %+50.93%
-16.76 %-48.77%
-32.71 %-277.81%
18.39 %+17.13%
15.70 %+727.80%
1.90 %-89.80%
18.61 %+66.93%
11.15 %-116.59%
-67.18 %+4,665.00%
-1.41 %-66.97%
-4.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Data Horizon Co Stock analysis

What does Data Horizon Co do? Data Horizon Co., Ltd generates revenue through its Medical-related Information segment, which offers medical-related information services and systems. The company develops software utilizing its proprietary medical databases, primarily targeting insurers with data health-related services. These services include analyzing insurers' receipt and medical checkup data to create health plans, optimize medical expenses, and promote health initiatives, such as notifying about generic drug usage. Additionally, Data Horizon provides a new polypharmacy service as part of its offerings. The company's primary customers are insurers, who purchase the data health services to support their healthcare business operations. Insurers use the data to analyze medical checkup trends, optimize spending, and implement health promotion strategies. The information systems developed by Data Horizon are tailored to meet the specific needs of insurers, enabling them to manage healthcare costs more effectively. Data Horizon's product portfolio includes medical-related information systems, data health services, and a new polypharmacy service. The medical-related information services focus on software solutions that process and analyze medical data, while the polypharmacy service addresses medication management for patients. These offerings are designed to support insurers in improving healthcare efficiency and reducing costs through data-driven insights. Data Horizon Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Data Horizon Co's Return on Equity (ROE)

Data Horizon Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Data Horizon Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Data Horizon Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Data Horizon Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Data Horizon Co stock

Return on Equity (ROE) of Data Horizon Co is 56.25 % in 2026.

Return on Equity (ROE) of Data Horizon Co changed from -1,782.91 % to 56.25 %, representing a -103.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Data Horizon Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Data Horizon Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Data Horizon Co

All Key Metrics — Data Horizon Co